Recent developments in targeted therapies

First results of a prospective bendamustine/rituximab trial in patients with MCL

MyPathway guidance of targeted therapy based on molecular profiles

Upfront autologous stem cell transplantation for newly diagnosed multiple myeloma

Advanced RET-rearranged NSCLC

Update on olaparib in ovarian cancer

First in-human trials of rovalpituzumab for SCLC

Impact of precision medicine in refractory malignancies

Large disparities found in BCRA testing across ethnicities

Phase I study of sapacitabine and seliciclib in patients with advanced solid tumours

Primary tumour location in metastatic colorectal cancer impacts overall survival

Chemotherapy combination with capecitabine extends survival after pancreatic cancer surgery